1 study found for:    16258544 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
Condition: Melanoma Stage III or IV
Intervention: Biological: Peptide-pulsed dendritic cells

Indicates status has not been verified in more than two years